Cancer diagnostics - 1 News by Life Technologies from Germany

Cancer diagnostics - 1 News by Life Technologies from Germany

image description

Mainz Biomed and Thermo Fisher Scientific sign collaboration agreement

Development of next-generation colorectal cancer screening product for global markets

14-Nov-2024 - Mainz Biomed N.V. announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. The collaboration agreement will enable Mainz Biomed and ...

cancer diagnostics bowel cancer cancer

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Haven't found the right news yet?

The analytica-world.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 7,504 lab and analytics news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now